Marshall Urist insider trades
Open-market stock purchases and sales by Marshall Urist, EVP, Research & Investments at Royalty Pharma plc, from SEC Form 4 filings since May 7, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 28, 2026 | RPRX Royalty Pharma plc | Sold | $239K |
| Aug 7, 2026 | RPRX Royalty Pharma plc | Sold (not open market) | — |
| Aug 5, 2026 | RPRX Royalty Pharma plc | Bought (not open market) | — |
| Jun 24, 2026 | RPRX Royalty Pharma plc | Sold | $502K |
| May 20, 2026 | RPRX Royalty Pharma plc | Sold | $722K |
| May 14, 2026 | RPRX Royalty Pharma plc | Sold | $726K |
| May 6, 2026 | RPRX Royalty Pharma plc | Bought (not open market) | — |
| Feb 11, 2026 | RPRX Royalty Pharma plc | Bought (not open market) | — |
| Jan 30, 2026 | RPRX Royalty Pharma plc | Sold | $822K |
| Jan 23, 2026 | RPRX Royalty Pharma plc | Sold | $805K |
| Jan 16, 2026 | RPRX Royalty Pharma plc | Sold | $790K |
| Jan 9, 2026 | RPRX Royalty Pharma plc | Sold | $816K |
| Jan 2, 2026 | RPRX Royalty Pharma plc | Sold | $770K |
| Dec 26, 2025 | RPRX Royalty Pharma plc | Sold | $786K |
| Dec 19, 2025 | RPRX Royalty Pharma plc | Sold | $768K |
| Dec 16, 2025 | RPRX Royalty Pharma plc | Sold | $766K |
| Dec 5, 2025 | RPRX Royalty Pharma plc | Sold | $914K |
| Dec 5, 2025 | RPRX Royalty Pharma plc | Sold | $714K |
| Dec 1, 2025 | RPRX Royalty Pharma plc | Sold | $932K |
| Dec 1, 2025 | RPRX Royalty Pharma plc | Sold | $728K |
| Nov 7, 2025 | RPRX Royalty Pharma plc | Bought (not open market) | — |
| Nov 7, 2025 | RPRX Royalty Pharma plc | Bought (not open market) | — |
| Nov 5, 2025 | RPRX Royalty Pharma plc | Bought (not open market) | — |
Companies traded
- RPRX Royalty Pharma plc: 26 sales, last Sep 28, 2026